Moderna announces vaccine efficacy of 94.1 per cent, to file for EUA with US FDA
Primary efficacy analysis of the Phase 3 COVE study of mRNA-1273 involving 30,000 participants included 196 cases of COVID-19, of…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.